Where next for antibiotics? The immune system and the nature of pathogenicity are providing vital clues in the fight against antibiotic-resistant bacteria.
作者信息
Hunter Philip
出版信息
EMBO Rep. 2012 Aug;13(8):680-3. doi: 10.1038/embor.2012.101. Epub 2012 Jul 6.
Abstract
摘要
相似文献
1
Where next for antibiotics? The immune system and the nature of pathogenicity are providing vital clues in the fight against antibiotic-resistant bacteria.抗生素的下一步发展方向在哪里？免疫系统和致病性的本质为对抗耐抗生素细菌的斗争提供了至关重要的线索。
EMBO Rep. 2012 Aug;13(8):680-3. doi: 10.1038/embor.2012.101. Epub 2012 Jul 6.
2
Nanoparticles subdue antibiotic-resistant bacteria's defences while enhancing innate immunity.纳米颗粒可抑制耐抗生素细菌的防御能力，同时增强先天免疫力。
Nat Nanotechnol. 2024 Jul;19(7):887-888. doi: 10.1038/s41565-024-01644-y.
3
Impact of vaccines on antimicrobial resistance.疫苗对抗微生物药物耐药性的影响。
Int J Infect Dis. 2020 Jan;90:188-196. doi: 10.1016/j.ijid.2019.10.005. Epub 2019 Oct 14.
4
Modified viruses deliver death to antibiotic-resistant bacteria.经过改造的病毒能杀死对抗生素具有耐药性的细菌。
Nature. 2017 Jun 21;546(7660):586-587. doi: 10.1038/nature.2017.22173.
5
Holding back the tide of antibiotic resistance.
Chem Biol. 2006 Jan;13(1):1-3. doi: 10.1016/j.chembiol.2006.01.001.
6
Vaccines and antibiotic resistance.疫苗与抗生素耐药性。
Curr Opin Microbiol. 2012 Oct;15(5):596-602. doi: 10.1016/j.mib.2012.08.002. Epub 2012 Sep 12.
7
Surviving innate immunity.存活的固有免疫
Trends Microbiol. 2002 Aug;10(8):358-9. doi: 10.1016/s0966-842x(02)02406-x.
8
Antibody-mediated crosslinking of gut bacteria hinders the spread of antibiotic resistance.抗体介导的肠道细菌交联可阻止抗生素耐药性的传播。
Evolution. 2019 Jun;73(6):1077-1088. doi: 10.1111/evo.13730. Epub 2019 Apr 22.
9
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.抗生素引起的肠道微生物群变化与疾病
Trends Mol Med. 2016 Jun;22(6):458-478. doi: 10.1016/j.molmed.2016.04.003. Epub 2016 May 10.
10
Fight against antimicrobial resistance.对抗抗菌药物耐药性。
Epidemiol Mikrobiol Imunol. 2018 Spring;67(2):74-80.
引用本文的文献
1
Identification and Characterization of T5-Like Bacteriophages Representing Two Novel Subgroups from Food Products.代表食品中两个新亚群的类T5噬菌体的鉴定与特性分析。
Front Microbiol. 2018 Feb 13;9:202. doi: 10.3389/fmicb.2018.00202. eCollection 2018.
2
Development of a novel antimicrobial screening system targeting the pyoverdine-mediated iron acquisition system and xenobiotic efflux pumps.开发一种针对绿脓菌素介导的铁摄取系统和外源性物质流出泵的新型抗菌筛选系统。
Molecules. 2015 Apr 29;20(5):7790-806. doi: 10.3390/molecules20057790.
本文引用的文献
1
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.肺炎球菌基因组测序追踪到一种通过多片段重组事件形成的疫苗逃逸变异体。
Nat Genet. 2012 Jan 29;44(3):352-5. doi: 10.1038/ng.1072.
2
A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.一种新型细菌耐药机制：链球菌表面蛋白 A 对人分泌型 IIA 组磷脂酶 A2 的作用。
J Immunol. 2011 Dec 15;187(12):6437-46. doi: 10.4049/jimmunol.1100499. Epub 2011 Nov 9.
3
Statins enhance formation of phagocyte extracellular traps.他汀类药物增强吞噬细胞细胞外陷阱的形成。
Cell Host Microbe. 2010 Nov 18;8(5):445-54. doi: 10.1016/j.chom.2010.10.005.
4
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.印度、巴基斯坦和英国出现新的抗生素耐药机制：一项分子、生物学和流行病学研究。
Lancet Infect Dis. 2010 Sep;10(9):597-602. doi: 10.1016/S1473-3099(10)70143-2. Epub 2010 Aug 10.
5
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.在美国，肺炎球菌疫苗接种后出现了疫苗逃逸重组体。
PLoS Pathog. 2007 Nov;3(11):e168. doi: 10.1371/journal.ppat.0030168.
6
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.蛋白质-多糖结合疫苗引入后侵袭性肺炎球菌疾病的下降
N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823.
Zotero 插件